Cernuda-Morollón, E., Martínez-Camblor, P., Serrano-Pertierra, E., Larrosa, D., Ramón, C., & Pascual, J. (2014). EHMTI-0105. CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine. Springer.
Chicago Style CitationCernuda-Morollón, E., P. Martínez-Camblor, E. Serrano-Pertierra, D. Larrosa, C. Ramón, and J. Pascual. EHMTI-0105. CGRP and VIP Levels As Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine. Springer, 2014.
MLA CitationCernuda-Morollón, E., et al. EHMTI-0105. CGRP and VIP Levels As Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine. Springer, 2014.
Warning: These citations may not always be 100% accurate.